278 participants
Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-19
- Start Date:
- 2017-09-28
- Completion:
- 2020-04-03
Conditions
- Obesity
Interventions
- DRUG